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acid binding and conformational stability of mutants of human muscle 
fatty acid-binding protein
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Department of Biochemistry, University of Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
Human muscle fatty acid-binding protein (M-FABP) is a 15 kDa 
cytosolic protein which may be involved in fatty acid transfer 
and modulation of non-esterified fatty acid concentration in 
heart, skeletal muscle, kidney and many other tissues. Crystal- 
lographic studies have suggested the importance of the amino 
acids Thr-40, Arg-106, Arg-126 and Tyr-128 for the hydrogen 
bonding network of the fatty acid carboxylate group. Two 
phenylalanines at 16 and 57 are positioned to interact with the 
acyl chain of the fatty acid. We prepared 13 mutant proteins by 
site-directed mutagenesis and tested them for fatty acid binding 
and stability. Substitution of amino acids Phe-16, Arg-106 or 
Arg-126 created proteins which showed a large decrease in or
complete loss of oleic acid binding. Substitution of Phe-57 by Ser 
or Val and of Tyr-128 by Phe had no great effect. The stability 
of the mutant proteins was tested by denaturation studies on the 
basis of fatty acid binding or tryptophan fluorescence and 
compared with that of the wild-type M-FABP. There was no 
direct relationship between fatty acid-binding activity and stab­
ility. Less stable mutants (F57S and Y128F) did not show a 
marked change in fatty acid-binding activity. Substitution of 
Arg-126 by Gin or Arg-106 by Thr eliminated binding activity, 
but the former mutant protein showed wild-type stability, in 
contrast to the latter. The results are in agreement with crystal- 
lographic data.
INTRODUCTION
After their transfer across the cellular membrane, fatty acids are 
bound to cytoplasmic fatty acid-binding proteins (FABPs) and 
transported to cellular organelles for ^-oxidation or for triacyl- 
glycerol or phospholipid synthesis [1]. FABPs may also be 
involved in the intracellular modulation of non-esterified fatty 
acid concentration [2].
FABPs are members of a family of conserved intracellular 
lipid-binding proteins and comprise at least eight types: liver, 
intestinal, heart or muscle, adipocyte, myelin, ileal, epidermal 
and brain [1-3]. Their family also includes cellular retinol- 
binding proteins I and II and cellular retinoic acid-binding 
proteins I and II. All FABPs are cytosolic, have low molecular 
masses of 14—16 kDa, and display sequence similarity of between 
38 and 70%. Human muscle FABP (M-FABP) is expressed in 
skeletal and cardiac muscle, kidney, testis and brain [4]. The 
protein binds long-chain fatty acids with a Ka of about 0.5 /¿M, 
showing a slight preference for unsaturated fatty acids [5].
The tertiary structures of myelin, intestinal (I-FABP), adi­
pocyte (A-FABP) and muscle FABP types were elucidated using 
X-ray analysis [6,7]. Their structural features arc similar and the 
proteins are composed of 10 antiparallel //-strands forming a ji 
barrel, and of two short a-helices. X-ray diffraction and multi­
dimensional NMR spectroscopy yielded a great deal of in­
formation about the three-dimensional structure of heart 
(muscle) FABP types [8,9], The three-dimensional structure of 
human M-FABP with bound fatty acid was resolved and refined 
by X-ray diffraction to 2.1 A resolution [8]. The carboxylate 
group of the fatty acid is located in the interior of the protein, 
where it forms hydrogen bonds with the side chains of Tyr-128
High-resolution X-ray studies on complexes of M-FABP with 
oleate, elaidate and stearate showed that these fatty acids are 
bound in a similar fashion [10]. The fatty acid is thought to enter 
the interior cavity of the protein via a portal in its surface, while 
interior solvent is released through a secondary opening. This 
opening is represented by the gap between /j-strands /?-D and 
fi-E and is formed by the hydrogen-bonding interactions of side 
chains of the ionizable residues Glu-72, His-93 and Arg-106. 
Thus Arg-106 seems to be simultaneously involved in hydrogen 
bonding to the bound fatty acid and in electrostatic interactions 
at the secondary portal.
Two of the eight hydrophobic and aromatic residues which 
make van der Waals contacts with the bound ligand are Phe-16 
and Phe-57. The phenyl ring of Phe-16 is in close proximity to the 
acyl chain and may be a key determinant of the ligand specificity 
and affinity of M-FABP [8]. The other aromatic residue, Phe-57, 
is within van der Waals distance from the terminal end of the acyl 
chain. In A-FABP, the orientation of the side chain of Phe-57 
represents the largest difference between the three-dimensional 
structures of the apo-and holo-proteins [11,12]. Probably it is 
involved in the exposure of the portal region. In holo-M-FABP 
a similar Phe-57 lid covers the portal, reducing access to the 
opening in the protein surface [10].
Until recently, no absolute deficiencies and no naturally 
occuring mutant proteins of the FABP family had been detected. 
This confirms the idea that this conserved group of proteins is 
essential to the cell and to the organism [1]. Very recently an 
amino acid substitution (A54T) was reported in the human I- 
FABP which was found to be associated with increased fatty acid 
binding, increased fat oxidation in vivo and insulin resistance 
[13]. This amino acid residue is located in a tight turn between
and Arg-126 and two ordered water molecules. One of these /?-strands C and D, which is critical in the conformational
water molecules is also hydrogen-bonded to Arg-106 and Thr-40. 
The fatty acid has a U-shape conformation in the binding cavity.
adjustment between the apo- and holo- forms of I-FABP [14]. 
To establish the importance of certain amino acid residues for
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the binding of fatty acids and the conformational stability of the 
human M-FABP, an approach of site-directed mutagenesis was 
used to construct mutant proteins with single amino acid 
substitutions. The sites for mutation were chosen on the basis of 
their possible importance for fatty acid binding or ligand affinity.
EXPERIMENTAL
Materials
Oligonucleotide primers were obtained from Eurogentec, 
Seraing, Belgium, and the Department of Haematology, Uni­
versity of Nijmegen; in vitro mutagenesis kit Muta-Gene M13 
was from Bio-Rad Laboratories, Richmond, CA, U.S.A.; Taq 
DNA polymerase was from Promega, Madison, WI, U.S.A.; 
Sequenase version 2.0 was from United States Biochemical, 
Cleveland, OH, U.S.A.; agar, casein hydrolysate (peptone), 
yeast extract, isopropyl /?-D-thiogalactopyranoside (IPTG), re­
striction endonucleases and urea were from Life Technologies 
Inc., Gaithersburg, MD, U.S.A.; anipicillin, kanamycin and 
tetracycline were from Sigma, St. Louis, MO, U.S.A. ; DEAE- 
Sepharose, Sephacryl S-100 Superfine and low-molecular-niass 
marker proteins were from Pharmacia Biotechnologies, Uppsala, 
Sweden; [a-35S]thio-dATP (37 TBq/mmol) and [l-14C]oIeic 
acid (204 GBq/mmol) were from Amersham International, Little 
Chalfont, Bucks., U.K.; Lipidex 1000 was from Canberra- 
Packard, Groningen, The Netherlands; fluorescent 2-(9-anth- 
royloxy)palmitic acid (2-AP) and 16-(9-anthroyloxy)palmitic 
acid (16-AP) were from Molecular Probes, Junction City, 
OR, U.S.A. Recombinant human M-FABP and liver FABP 
(L-FABP) were prepared as described [5,15]. All other reagents 
were of analytical grade.
reverse primer, 5'-ATCACCAGTGGATCCAGGTCATGC- 
CTC-3' [5]. The PCR amplification reactions were carried out in 
a total volume of 50 /¿I containing 10 pmol of each primer, 
250 nM of each dNTP, 2.5 units of Taq DNA polymerase and 
1.5 mM MgCl2 in 50 mM KC1/10 mM Tris/HCl, pH 9.0/0.1 % 
Triton X-100. After 5 min denaturation at 95 °C, 30 cycles of 
amplification were carried out: 95 °C for 1.5 min; 60 °C for 
1 min; 74 °C for 2 min. The PCR products were purified by 
phenol/chloroform extraction and ethanol precipitation. The 
amplified and purified mutant cDNA fragments were digested 
with Ncol and BamHl and the digested products were ligated 
with a modified pGEM-5Zf( + ) vector, which had previously 
been digested with the same enzymes. The nucleotide sequences 
of the mutant coding regions were verified. Nucleotide sequencing 
was performed using the dideoxy chain termination technique 
with [:!SS]thio-dATP and the Sequenase kit on either double­
stranded or single-stranded pGEM vectors.
Oligonucleotide-directed in vitro mutagenesis
To prepare site-directed mutations in the cDNA coding for
human M-FABP, the Muta-Gene M13 in vitro mutagenesis kit
instructions were basically followed. The method used is based
on the uracil selection technique [16-18]. ThecDNA of M-FABP
in M13mpl8 [19] was used in oligonucleotide-directed muta­
genesis. The target amino acid residues for mutation and the instead of 70 % saturation. Proteins were > 95 % pure on basis
oligonucleotides which were used as mutagenic primers are of SDS/PAGE/Coomassie Brilliant Blue staining. All proteins
shown in Table 1. Identification of the mutant cDNAs was done were concentrated to 1-3 mg/ml and kept at —80 °C until use.
by sequence analysis by the dideoxy chain termination technique Proteins were delipidated before binding studies [22]. 
using [;i!iS]thio-dATP and the Sequenase kit.
Expression and purification of mutant M-FABP
The primers used during amplification of mutant M-FABP 
cDNA contain recognition sites for the restriction enzymes Ncol 
and BamHl, which facilitate directional cloning in pET-3d 
(formerly pET-8c) [20], The sequenced mutant M-FABP cDNAs 
were isolated after digestion with Ncol and BamHl and ligated 
with pET-3d vector previously digested with the same enzymes. 
The plasmids pET-3d/mutant M-FABP were used to transform 
the Escherichia coli B strain BL2I(DE3) [20,21]. A 5 ml overnight 
culture of cells coding for the mutant FABP was used to 
inoculate 1 litre of 2YT medium (1.6% casein hydrolysate/1 % 
yeast extract/0.5 % NaCl; all w/v). Large cultures were per­
formed in 2 litre flasks containing 1 litre of medium. Bacteria 
were grown under shaking at 37 °C. At an ASB0 of 0.5-1.0, 
protein expression was induced with 0.5 mM IPTG and in­
cubation was continued for 3 h at 37 °C.
The procedure for purification of the different mutant FABPs 
was essentially as for the wild-type M-FABP [5], except that 
ammonium sulphate was added to the supernatant up to 50 O/O
Cloning and sequencing of mutant FABP cDNA
Primers derived from the muscle FABP cDNA sequence were 
designed so as to amplify the mutated coding region: forward
primer, 5'-GCCAGCATCACCATGGTGGACGCTTTC-3/ ;
Table 1 Oligonucleotides used in in vitro mutagenesis
The nucleotide positions which were targets for mutagenesis are in upper case. The nucleotides 
in square brackets were mixed In equal amounts during synthesis of the oligonucleotides. N 
indicates each of the four nucleotides.
Effect of fatty acid binding on quenching of tryptophan 
fluorescence
The tryptophan fluorescence of 1 /¿M delipidated proteins was 
measured over the wavelength range 300-400 nm at an excitation 
wavelength of 283 nm (5 nm slits) with a Shimadzu RF 5000 
spectrofluorophotometer. The fluorescence was analysed for 
1.0 /¿M delipidated protein in the absence or presence of 1.25 /¿M 
oleic acid in 1 ml of 10 mM Tris/HCl, pH 8.0/1 % ethanol at 
25 °C. All values were corrected for the same mixture of 10 mM 
Tris/HCl, pH 8.0/1 % ethanol without protein.
Target amino acid residue Oligonucleotide used
Phe-16 5'-gac age aag aat [TG][N][CG] gat gac tac atg-3'
Thr-40 5'-g cct acc [GC][AT]a ate ate gaa aag-3'
Phe-57 5'-ca cac age acc [TAG][TC][AG] aag aac aca gag-3'
Arg-106 5'-ca ctt gtg ACg gag eta att g-3'
Arg-126 5'-gca gtt tgc act [CA]a[TG] act tac gag-3'
Tyr-128 5'-c act ege act [TA]t[CG] gag aaa gag g-3'
Fluorescence enhancements of fluorescent fatty acids with 
L-FABP, M-FABP and mutant M-FABPs
All fluorescence experiments were carried out using a Shimadzu- 
500 fluorimeter. The fluorescence was analysed of 1.0 /¿M anthro- 
yloxy-labelled fatty acid in the absence or presence of 4.0 /¿M 
FABP in 1 ml of 10 mM Tris/HCl, pH 8.0/1 % ethanol at 25 °C. 
The fluorescence was determined between 400 and 500 nm at an 
exitation wavelength of 365 nm and a band width of 5 nm.
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Protein dénaturation studies
Fatty acid binding was measured at 2 [ l- llC]oleic acid and
1 ¡i.M protein using the Lipidex procedure. We used urea stock 
solutions of 9.6 M and 11.2 M (pre-warmed at 37 °C) to obtain 
urea concentrations of 0-7 M in 400 /à of incubation mixture. 
This mixture was prepared as follows. First a volume of urea 
stock solution was diluted with 10 mM Tris/HCl, pH 8.0, to 
obtain the required final concentration of urea ; then delipidated 
protein was added to a final concentration of 1 fiM and this 
mixture was incubated for 10 min at 37 °C. Then [l-MC]oleic acid 
was added to a final concentration of 2 //.M, gently mixed and 
incubated for 15 min at 37 °C. From here on, the Lipidex 
procedure was followed [22]. Curve fitting by a computer program 
was used to determine the concentration of urea giving half the 
initial binding activity (midpoint).
Equilibrium unfolding as a function of dénaturant concen­
tration was monitored by fluorescence spectroscopy in the 
presence of urea or guanidine hydrochloride (GdnHCl). The 
tryptophan fluorescence of 1 /iM  delipidated protein was mea­
sured by the shift of the maximum emission wavelength at an 
excitation wavelength of 283 nm (5 nm slits) using a Shimadzu 
RF 5000 spectrofluorophotometer. Stock solutions of déna­
turants were 9.6 M for urea and 6 M for GdnHCl. A mixture of 
urea, 10 mM Tris/HCl, pH 8.0, and protein was incubated for
15 min at 37 °C before measuring the fluorescence. All values 
were corrected for the same mixture of urea/10 mM Tris/HCl, 
pH 8.0, without protein. The emission wavelength yielding 
maximum fluorescence was plotted against dénaturant con­
centration for each sample to visualize the unfolding profile. 
Curve fitting by a computer program was used to determine 
[D]50, the concentration of dénaturant at the midpoint o f the 
transition.
Dénaturation curve analysis
In order to analyse the dénaturation curves, the émission
type and mutant proteins [23,28]. The value of/» used is obtained 
from the unfolding curve of apo-M-FABP with the same 
denaturant. Eqn. (3) gives AAG\ the difference in free energy of 
unfolding of wild-type and mutant proteins in the presence of 
denaturant, but avoids the uncertainties inherent in estimating 
differences in AG” , values.U| IJ)
Other procedures
Standard procedures were used for SDS/PAGE. Protein con­
centration was determined by the procedure of Lowry et al. [29] 
with BSA as standard. A comparative assay of the fatty acid- 
binding activity of M-FABP and the mutants was performed 
with 1 //M protein at 2 //.M [l-1,lC]oleic acid according to the 
Lipidex procedure [22]. The dissociation constant (A',) for the 
binding of [ l- t<lC]oleic acid to M-FABP and the active mutant 
proteins was determined at 0 .1-2 .0 /¿M fatty acid and 0.5 /iM 
protein [30]. Protein samples were first delipidated with Lipidex 
1000 at 37 °C [22]. The binding parameters were obtained from 
Scatchard plot analysis.
R E S U L T S  
Mutagenesis and expression of mutant FABPs in E. coli
By using oligonucleotides which had ‘wobbles’ on the target 
position of mutation, we were able to prepare 23 different 
cDNAs coding for mutant M-FABPs. Only for Arg-106 was a 
specific primer used. The mutant cDNAs included seven mutants 
with amino acid substitutions at position Phe-16: Cys, Asp, Gly, 
Glu, Ser, Val and Tyr; lour mutants at position Thr-40 : Glu, 
Leu, Gin and Val; three mutants at position Phe-57: Ala, Ser 
and Val; one mutant at position Arg-106: Thr; three mutants at 
position Arg-126: His, Lys and Gin; and three mutants at 
position Tyr-128: Phe, Leu and Met. Two mutants with double 
amino acid substitutions were isolated for positions 16 and 57: 
Lcu/Leu and Asp/Val. Among the 14 mutant proteins which
maximum wavelength was used to follow unfolding. From a were expressed during this study, one mutant protein (Y128L) 
measurement of the equilibrium constant K  (the ratio of the was not expressed as a soluble protein in Li. cotu but instead 
fraction of molecules in the denatured state to the fraction in the accumulated in inclusion bodies. This mutant protein was not
native state), the free energy change on conversion of a molecule 
to the denatured state can be calculated from the equation:
A G RUnK ( 1)
The value of AG is the fundamental measure of the stability of a 
protein with respect to reversible dénaturation. The data from 
the denaturant-induced unfolding curves were analysed in this 
way. When the dénaturants urea or GdnHCl arc used to vary the 
solvent composition, AG has been found to obey the simple 
linear relationship :
used in this study. All other mutant FABPs were more or less 
soluble and gave rise to yields comparable with those of the wild- 
type protein. For all mutant proteins the same purification 
scheme was used as for the wild-type protein [5]. All soluble 
mutants of M-FABP had comparable secondary structures to 
that of the wild-type protein, as detected by Fourier-translbnn 
1R spectroscopy (results not shown). This is consistent with the 
finding that large structural changes in proteins as a result of a 
single mutation are rare [31 33].
AG =  AG•*{>Upp m • [D] ( 2 )
where AG"UI)J, is the apparent Gibbs free energy in the absence of
denaturant and [D] the concentration of denaturant. The value 
of m (i.e. d(AG)/d[D]) is determined over the denaturant con­
centration range where values of AG can be measured. AG", can
be determined by linear extrapolation of the data to zero 
dénaturation concentration [23-27], Another procedure used 
takes advantage of the reproducibility in measuring the con­
centration of denaturant giving 50% unfolding, [D]m). Eqn. (2) 
may be used for comparison of wild-type and mutant proteins to 
give:
AAG = m • A[D]no (3)
where A[D]50 is the difference between the [D]50 values for wild-
Ligand-binding activity of M -F A B P  mutants
Analysis by radiochemical assay
Because oleic acid was one of the fatty acids that showed the 
highest affinity for M-FABP [5,15], this fatty acid was used in 
comparative binding studies. Binding activities were measured at 
pH 8.0 with excess oleic acid over protein, and expressed relative 
to the binding activity of wild-type M-FABP (Table 2). For the 
proteins which showed a relatively high binding activity, the Ka 
values were also determined.
Replacement of Phe-16 by polar serine resulted in the elim­
ination of binding activity for oleic acid. Replacement by 
hydrophobic valine or polar tyrosine led to a decrease in binding 
activity. The introduction of negatively charged glutamic acid at 
position Thr-40 greatly decreased oleic acid binding, whereas
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Table 2 Binding of [14C]oleic acid by wild-type M -FA B P  and M -F A B P  
mutants and effect of urea dénaturation
Binding activities were measured at 2 /M  [1 -14C]oleic acid and 1 /¿M protein by the Lipidex 
procedure, Values are the means ± S ,D . of live independent assays. K6 values for oleic acid 
were derived from three Scatchard plots of binding assays at 0 .1 -2  /¿M oleic acid and 0.5 
protein, Binding activity of M-FABP amounted to 32 ± 4  nmol/mg of protein. The midpoint is 
the concentration of urea at which 50% of the binding activity was reached, and was derived 
from the curves given in Figure 2. Values for midpoints are means ± S .D . for three independent 
experiments.
Preparation Relative binding activity Ka (fiM) Midpoint (M)
Wild-type M-FABP 1.00 0.43 ± 0 ,0 5 5.8 ± 0 . 3
F16S 0.01 ±  0.01 — —
F16V 0 .2 5 + 0 .1 3 1.50 ± 0 .3 5 2.3 ± 0 .1
F16Y 0.35 +  0.11 1.16 ±  0.07 1.4 ± 0 . 3
T40E 0.09 +  0.07 m M
T40Q 0.87 +  0.22 0.62 ± 0 .1 9 5 .4 + 0 .2
T40V 1.08 ±  0.11 0.46 ±  0.23 5.6 ± 0 . 2
F57S 1.05 ± 0 .1 7 0.38 ±  0.09 3.2 ± 0 . 5
F57V 1.22 ±  0.08 0.35 ± 0 .0 8 5.3 ± 0 . 0
R106T 0.03 ±  0.02 ----- -----
R126H 0.34 ± 0 .1 3 0,85 ±  0.03 1.9 ±  0.2
R126K 0.25 ± 0 .1 1 2.14 ±  0.87 1.6 ± 0 . 3
R126Q 0.04 ± 0 .0 2 — — *
Y128F 0.78 +  0.19 1.02 +  0.38 3 .4 + 0 .3
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Figure 1 Effect of urea dénaturation on the oleic acid binding and 
tryptophan fluorescence of M -F A B P
The continuous line shows the decrease in oleic acid binding activity upon denaturant-induced 
unfolding, given as a percentage of the initial binding activity (left y-axis). The broken line 
reflects the shift in emission maximum upon dénaturation, as monitored by the fluorescence 
emission wavelength (right y-axis). The exitation wavelength was 283 nm. Results represent the 
means ± S ,D ,  of three independent experiments.
substitution of polar glutamine (T40Q) or non-polar valine 
(T40V) did not affect binding activity. Substitution of serine or 
valine for Phe-57 did not affect binding activity. Substitution of 
polar threonine for the positively charged Arg-106 resulted in no 
detectable binding activity for oleic acid. Replacement of Arg- 
126 by other positively charged amino acids such as histidine or 
lysine decreased binding activity; replacement with glutamine 
eliminated it. Finally, substitution of phenylalanine for Tyr-128 
resulted in a moderate decrease in binding activity.
Dissociation constants (Ka) of the mutant proteins were in 
agreement with their binding activities. Mutants with normal 
binding activity (T40Q, T40V, F57S and F57V) showed a wild- 
type KiV whereas mutants with decreased binding activity (F16V, 
F16Y, R126H, R126K and Y128F) showed an increased Ka.
Analysis by fluorescence assay
The effects of mutation of the protein were also tested using the 
fluorescent fatty acids 2-AP and 16-AP. These fatty acids, with 
hydrophobic side groups, presumably bind to the surface of  
M-FABP [15]. The fluorescence increases for the interactions 
o f M-FABP and the mutant proteins were much higher with 2-AP 
than with 16-AP. With 2-AP, however, all mutant M-FABPs 
except for R106T showed no blue shift of the maximal emission 
wavelength (456 nm), as for M-FABP. The fluorescence increase 
varied considerably (0.7-2.2 times that of M-FABP). Mutant 
R106T, which has Thr at position 106 like L-FABP, showed a 
blue-shift in the emission maximum to 443 nm, like L-FABP
[15], but only 50% of the fluorescence increase. With 16-AP, 
maximal emission wavelengths were the same for all mutant 
proteins as for wild-type M-FABP. The fluorescence increases 
o f  the mutant proteins showed 2.5-8.3-fold higher values than 
that of the wild type, except those of F16S and F16Y, which 
were similar.
Fatty acid binding under denaturating conditions
For this type of study, only mutants were used which showed 
binding activity for oleic acid of at least 25 % of that of the wild 
type. The assay would otherwise be too inaccurate to detect the 
effect of urea dénaturation. M-FABP shows a remarkable 
insensitivity to urea: at 5 M urea 75% of the initial binding 
activity remained (Figure 1 ). The initial binding activity decreased 
to 50 % (midpoint) at a urea concentration of 5.8 M.
The effect of urea treatment on the binding activities of M- 
FABP and its mutants is shown in Figure 2, and the midpoints 
of urea dénaturation are given in Table 2. The two proteins with 
mutations at amino acid position 16 showed a markedly lower 
stability with respect to binding activity than M-FABP (Figure 
2A), while the two proteins with mutations at position 40 showed 
similar changes in binding activity upon urea treatment as 
M-FABP (Figure 2B). The binding activity o f the F57S protein 
was more sensitive to urea dénaturation than that of the F57V 
mutant, which had wild-type activity and structural stability 
(Figure 2C).
Arg-126 and Tyr-128 are thought to play an important role in 
the electrostatic network by which the fatty acid is bound [8,10]. 
Three proteins containing mutations of these amino acids showed 
a much higher (R126 mutants) or a higher (Y128F) loss of 
binding activity upon urea treatment than M-FABP (Figure 2D).
Effect of urea dénaturation on tryptophan fluorescence
The stability of the structures of M-FABP and the M-FABP 
mutants was further evaluated by examination o f the fluorescence 
spectra of the proteins. The intrinsic fluorescence of M-FABP 
arises primarily from two tryptophans, Trp-8 and Trp-97. 
Crystallographic studies on M-FABP indicated that Trp-8 lies 
internally on /?-strand A, while Trp-97 is on strand G, just before 
the /?-turn between strands G and H [8]. The two Trp residues do 
not seem to be involved in the fatty acid-binding centre on the 
basis of their positions in the protein, unlike in I-FABP where
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Figure 2 Effect of urea dénaturation on the oleic acid binding activity of wild-type and mutant M -F A B P s
Binding activity is given relative to that of the wild-type protein, which had a binding activity of 22 pmol///.g of protein at 0 M urea. In each panel, the curve for M-FABP is shown by filled circles. 
Curves are shown for proteins containing mutations at position 16 (A), position 40 (B), position 57 (C) and positions 126 and 128 (D). Results represent the means ±  S.D. of three independent 
experiments.
Trp-82 interacts with the fatty acid and can therefore be used in 
the assessment of ligand binding in fluorescence experiments 
[14,34]. The consequences of the location of the two Trp residues 
in M-FABP for fatty acid binding were confirmed by the 
observation that the Trp fluorescence of the M-FABP and all 
mutant proteins did not differ significantly in the presence and 
absence of bound oleic acid (results not shown). When fluor­
escence was measured at 332 nm, differences in fluorescence up 
to a factor of 3 could be detected among the mutant M-FABPs. 
Mutants T40E, T40Q, T40V, F57S and R I26H showed decreased 
fluorescence compared with wild-type M-FABP, whereas mut­
ants F 16V, F16Y, F57V, R106T, R126K, R126Q and Y128F 
showed wild-type or slighly higher values (results not shown).
Complete dénaturation of M-FABP with urea resulted in a 
red-shift of the fluorescence emission maximum from 332 nm to 
354 nm (Figure 1). The unfolding transition occurred in the 
range 5-7 M urea, like the decrease in binding activity. The 
fluorescence intensity first showed a decrease at a concentration 
of 6 M urea, indicating that the tryptophan residues in M-FABP 
are more exposed to the solvent at this urea concentration 
(results not shown).
Because the effects of urea on binding activity could only be 
studied with mutants having at least 25",, binding activity, we 
used Trp fluorescence especially in dénaturation .studies with 
the non-binding mutant proteins. The transition profiles for 
M-FABP and the M-FABP mutants are shown in Figure 3. All 
curves follow similar patterns, although the midpoints of the 
transitions vary and the initial wavelength, at which the fluor­
escence was maximal, also varies. Figure 3(A) shows that GdnHCl 
is a much stronger dénaturant than urea. With both dénaturants 
apo-M-FABP showed a less stable structure than M-FABP with 
oleic acid as ligand. The curves for the mutant proteins F16Y, 
F57S and Y128F followed similar patterns as for apo-M-FABP, 
although the midpoints of transitions occurred at much lower 
urea concentrations (Figure 3B), The three proteins with muta­
tions at Thr-40 showed more diversity : T40E and T40Q were less 
stable thanT40V, which has a wild-type transition profile (Figure 
3C). The mutant protein T40E had the lowest stability to urea 
dénaturation. Mutant proteins R106T and R126K showed a 
midpoint of transition at a lower urea concentration than apo- 
M-FABP, whereas R126Q showed a wild-type transition profile 
(Figure 3D). For most investigated mutants, the midpoints of the
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Figure 3 Shift in the tryptophan emission maximum of wild-type and mutant M -F A B P s  on denaturant-induced unfolding
The tryptophan fluorescence of proteins was measured at 1 /M  concentration and at an excitation wavelength of 283 nm. Emission spectra were recorded from 300 to 400 nm. (A) Open symbols, 
apo-M-FABP; filled symbols, oleic acid-bound M-FABP; the type of denaturant used is Indicated. In (B), (C) and (D), urea was used as denaturant; the curve for apo-M-FABP Is always given 
for comparison. Results represent the means ±  S.D. of three independent experiments.
urea concentration causing unfolding ([D]n0) were higher (Table 
3) than the midpoints of the decrease in fatty acid binding 
activity (Table 2). This indicates a higher sensitivity of the 
binding centre.
Estimation of the conformational stability by reversible 
dénaturation
By analysis of urea and GdnHCI dénaturation curves (Figure 3) 
it is possible to obtain an estimate of the conformational stability, 
i.e. the apparent Gibbs free energy of the protein, AG°iiw. The 
emission maximum wavelength was used for following unfolding. 
All proteins studied appear to closely approach a two-state 
mechanism in which only the native state and the denatured state 
are present at significant concentrations in the transition region.
Two methods were used to estimate the conformational 
stability of the mutant M-FABPs, and the results were compared. 
In the first method A G was estimated with the assumption that 
the linear dependence of AC? on denaturant concentration obser­
ved in the transition region continues to zero concentration [231.
There is convincing evidence that this linear extrapolation 
provides a good approximation for nearly all monomeric single- 
doniain proteins [24,26,27]. This method was used to analyse the 
data from Figure 3, and the results are given in Table 3. The AG 
values of apo- and holo-M-FABP were lower on the basis of the 
GdnHCI dénaturation data compared with the urea data, indica­
ting the impoi’tance of electrostatic interactions to these proteins 
[35]. With both dénaturants, the apo-protein was less stable than 
the holo-protein. Therefore mutant and wild-type proteins were 
compared after delipidation. Only mutants T40V and R126Q 
showed an apparent Gibbs free energy similar to the value of 
wild-type M-FABP, whereas the other mutants show a con­
siderable lower AG"
The second procedure involves calculation of the difference in 
the energy of unfolding between apo-M-FABP and holo-M- 
FABP or M-FABP mutants in the presence of denaturant. This 
method takes advantage of the reproducibility in measuring [D]fl0 
and is suitable in the mutational analysis of a protein [23,24]. 
The stability differences between apo-M-FABP and each of 
the mutant proteins (AAG) can be estimated by multiplying the
apiv
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Table 3 Conformational stability and transition midpoints for the denaturant-induced unfolding of wild-type M - F A B P  and nine mutant M -F A B P s
Equilibrium unfolding was measured by the change in intrinsic tryptophan fluorescence at 25 °C in the presence of Increasing concentrations of denaturant (D). A G °ap|)1 the apparent free energy 
difference between the folded and unfolded forms of the protein, was determined by linear extrapolation of the data to zero denaturant concentration, m is the slope of the linear denaturation plot, 
— dAG/d[D], [D]50 Is the concentration of denaturant at which 50% of the protein is unfolded. For each protein d (A S) was determined by comparison of the free energy of unfolding around [D ]50. 
The difference A A G was calculated as m- A [D ]50 relative to apo-M-FABP. For m the value derived from the transition curve of apo-M-FABP was always used (see the te x t ) , ' Holo’ indicates 
M-FABP with oleic acid as ligand. All mutant proteins were delipidated. Data are means ± S .D .  of three independent experiments.
Denaturant Protein [Dkn (M) AG°„„„ (kJ/mol)app m (kJ/mol • M) A A  G (kJ/mol)
Urea
GdnHCI
Apo
Holo
F16Y
F57S
Y128F
T40E
T40Q
T40V
R106T
R126K
R126Q
Apo
Holo
6,0 + 0.02
6.7 +  0.01 
4.9 +  0.01 
5.2 +  0.08
5.0 ± 0 ,0 5
5.0 ± 0 .0 8  
5.3 ± 0 .1 2  
6.2 ± 0 .0 3  
4.6 ±  0.04
4.8 ±  0.16
6.0 + 0.00
1.88 +  0.01 
2.17 +  0.01
45.5 ± 5 .6
49.1 ± 0 .9
31.1 ± 1 .6  
30.3 ± 2 .5
29.5 ± 0 .6
31.8 ± 6 .0
27.2 ± 1 . 7
37.8 ± 3 .7
30.7 ± 1 .7
26.0 ± 4 .3
42.9 ± 6 .9
28.8 ± 0 .6
37.0 +  2.7
7.6 +  0.8 
7 . 3 +  0.2
6.3 +  0.2 
5.9 +  0.4 
5 . 9 +  0.1
6.3 +  1.1
5.3 +  0.2 
6 . 2 +  0.7 
6 . 6 +  0.4 
5.5 +  0.6
7.3 +  1.1
14.6 ± 0 . 6  
16.8 +1.6
- 5 .3  ± 0 . 6  
8,4 ±  0.9 
6.1 ± 0,6
7.6 ± 0 . 8
7.6 ± 0 . 8  
5.3 ± 0 . 6
- 1 .5  +  0.2  
10.6 ± 1.1 
9.1 ±  1.0  
0.0 + 0.0
4 . 2 +  0.2
difference between the [D]50 values by the m value derived from 
the transition curve of apo-M-FABP (Table 3). Using this 
method, the differences in conformational stability between apo-
observed in mutants of L-FABP in which Arg-122 was replaced 
by Lys, Gin or Ala, or Arg-126 was replaced by Lys [38], 
Compared with the arginine residues, Tyr-128 is more tolerant
and holo-M-FABP obtained from the curves achieved with to substitution in M-FABP, since it can be substituted with Plie
urea and GdnHCI are about the same. In general, the differences 
between the AG°avp values for wild-type and mutant proteins are 
similar but somewhat larger than the AAG values calculated, due 
to the uncertainty of the AG° values, which are obtained by
without a large change in binding activity. On the other hand, 
substitution of Tyr-128 by Trp in A-FABP caused a greatly 
decreased binding affinity for m-parinaric acid [37]. Tyr-128 is 
not so well conserved throughout the family of FABPs as are 
Arg-106 and Arg-126, since I-FABP has Phe at position 128.
Mutation of Thr-40 caused a large variation in binding activity, 
The introduction of a negatively charged carboxylate (T40E) 
probably interferes with the capture of the carboxylate group of 
the fatty acid in the electrostatic network in the internal cavity of 
M-FABP. The involvement of Thr-40 in the hydrogen-bonding 
network [8] does not appear to be essential, because substitution 
proteins, but all mutants had a lower value than the wild type. If of valine or glutamine for threonine does not change the fatty
extrapolation (Table 3).
The mutant proteins with the greatest difference in A(y’upp 
compared with apo-M-FABP also showed the largest difference 
in stability (AAC). Mutants T40V and R126Q, which showed the 
smallest difference in AG°am), also deviated least in stability by the 
second procedure: they showed nearly wild-type stability. No 
large differences in the value of m were observed among mutant
an average of the m values of the mutant proteins is used to 
calculate the mutant’s effect on stability instead of the m value of 
apo-M-FABP, as suggested by others [24,28] for mutant proteins, 
the results are the same.
DISCUSSION
Various studies on FABPs, cellular retinol-binding proteins and
acid-binding activity.
Other mutants tested had amino acid substitutions at positions 
Phe-16 and Phe-57, which are thought to be involved in the 
interaction with the acyl chain of the fatty acid. Phe-16 showed 
a low tolerance to substitution. The phenyl ring seems to be 
required for interaction with the fatty acid, since mutation to Tyr 
disrupted binding. The phenyl ring of Phe-57 seems less critical, 
since the replacement of this amino acid by Ser or Val resulted
cellular retinoic acid-binding proteins showed the importance of in wild-type binding activity.
the amino acid residues at positions 106 and 126 for ligand 
binding (for references see [1,2]). Among the family of FABPs, 
Arg-106, Arg-126 and Tyr-128 are conserved in intestinal, heart, 
adipocyte, myelin and epidermal FABPs. In this study we show
The binding o f the anthroyloxy-labelled fatty acids to M- 
FABP and the mutants must occur at the surface, since their 
fluorescence increase was low with these proteins, in contrast 
with L-FABP [15]. Furthermore, we observed no shifts in the
that Arg-106 seems essential for the fatty acid-binding activity of emission wavelength maximum upon binding, except for the
M-FABP. Furthermore, a specific role for Arg is indicated at mutant R106T. Also, all mutant proteins of M-FABP, irres-
position 126, since mutants with other positively charged residues pective of whether they bound oleic acid, showed a fluorescence 
(R126L, R126K) showed a considerable decrease of binding increase. The binding affinities of fusion proteins of the A-FABP
activity. In 1-FABP, substitution of Gin for Arg-106 also mutants R126Q and Y128W did not change compared with the
decreases the affinity for fatty acids by 20-fold [34]. Complexes wild type with 12-(9-anthroyloxy)oleic acid as ligand, but were 
between this mutant I-FABP and oleate showed a destabilization decreased 30-50-fold with c/.v-parinaric acid [37]. This suggests a
of the electrostatic network [36]. In A-FABP, mutation of Arg- binding mechanism other than the carboxylate electrostatic
126 to Gin caused a greatly decreased affinity for c/.v-parinaric network for the former ligand.
acid [37]. A 2-4-fold decrease in binding affinity for 11- The binding activity of M-FABP shows remarkable stability
dansylamino-undecanoic acid (DAUDA) and/or oleic acid was towards a non-ionic chaotropic agent such as urea (Figure 1).
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Destruction of the external water structure decreases generally 
the hydrophobic character of proteins. M-FABP and its family 
members, however, contain a folding motif which is designated 
an up-and-down / -^barrel [7]. This structure, which is formed by 
many intramolecular hydrogen bonds, is probably not susceptible 
to destruction of the water structure around the protein. Urea 
has its effect on the internal water-filled cavity, since the transition 
of M-FABP to the denatured state is concomitant with the 
decrease in binding activity (Figure 1). The denaturation curves 
presented in Figure 1 display no sigmoidal unfolding kinetics, in 
contrast to DAUDA binding by L-FABP in the presence of urea 
[38]. Furthermore, our [D]&0 value for M-FABP was considerably 
higher than that for L-FABP [38].
The midpoint concentrations of urea, i.e. those at which 50 % 
of the initial binding activity was lost, showed some relationship 
with the relative binding activities for oleic acid, but not in all 
cases. The F57S and R126H mutants showed similar binding 
activity as M-FABP, but their binding centre was less stable 
(Table 2). When the conformational stability of the proteins in 
the presence of urea was tested, the midpoint concentration was 
generally higher (Table 3) than that for inactivation of the 
binding centre (Table 2). Of all mutant M-FABPs tested, only 
T40V and R126Q showed wild-type stability; the former mutant 
protein showed similar binding activity and stability of the 
binding centre as M-FABP, in contrast to the latter. F57S and 
Y128F showed no or a slight change in binding activity compared 
with the wild type, but urea affected strongly the binding centre 
and the stability of the protein.
The ionic chaotropic agent GdnHCl causes denaturation of  
M-FABP at lower concentrations than urea, since it disturbs the 
intramolecular electrostatic network. The AG°ttpp values for apo- 
and holo-M-FABP calculated from the curves with urea as 
denaturant are in agreement with the results for apo- and holo- 
I-FABP [39], The AG°app values with GdnHCl as denaturant are 
about 7 kJ/mol higher for M-FABP than for I-FABP, but this 
could be due to the internal location of Trp-82 and its involvement 
in the hydrogen-bonding network o f I-FABP [40,41]. The ap­
parent Gibbs free energy found for the unfolding of apo-A- 
FABP is approximately 3 times lower [42] than we found for apo 
M-FABP, although their structures share several characteristics 
such as the location of the Trp residues and the electrostatic 
network of Arg-106, Arg-126 and Tyr-128 [10,11].
In conclusion, the assays of oleic acid binding and confor­
mational stability showed distinct differences between the mutant 
M-FABPs tested, and also between mutants with different amino 
acid substitutions at the same position. There was no clear 
relationship between fatty acid-binding activity and stability. 
Mutants T40Q, T40V and F57V showed no change in either fatty 
acid binding or stability, R126Q had a stability similar to that of 
M-FABP but no binding activity, and F57S and Y128F showed 
only a large decrease in stability, with little or no effect on 
binding. These results are in agreement with crystallographic 
data on the importance of Arg-106, Arg-126 and Tyr-128 for the 
electrostatic network of M-FABP and on the role of Phe-16 in 
the interaction with the fatty acid. The implications of the 
mutations for other properties of M-FABP (e.g. fatty acid 
transfer) remain to be explored.
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